Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®
NCT ID: NCT00893243
Last Updated: 2009-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27 participants
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To compare the efficacy in treating dry eye syndrome in contact lens wearers or computer users of Tears Again® versus Opticol® versus Optive®
Secondary Purpose:
* Subjective evaluation of symptomatology
* Evaluation of preference in different kind of administration - spray versus monodoses versus multi-doses
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye
NCT00399230
Efficacy Study of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye Complaints
NCT01543061
Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye
NCT00724412
Clinical Trial Protocol for Safety and Efficacy of Soft Contact Lens
NCT04299243
Acute Comfort and Blur of Systane and Optive
NCT00568386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1Tears Again/Control
No interventions assigned to this group
2Opticol/Control
No interventions assigned to this group
3Optive/Control
No interventions assigned to this group
4Tears Again/Opticol
No interventions assigned to this group
5Tears Again/Optive
No interventions assigned to this group
6Opticol/Optive
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>18 years and \< 55 years
* Daily wearer of soft contact lens and/or daily (\> 4 hours/day) computer user
Exclusion Criteria
* Ocular or systemic disease that can affect the normal tear film
* Pregnancy or pregnancy risk (no contraceptive method), lactation
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de Sao Sebastiao
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MD, Ophthalmologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lilianne Duarte, MD
Role: PRINCIPAL_INVESTIGATOR
Ophthalmologist
José Salgado-Borges, PhD
Role: STUDY_DIRECTOR
Ophthalmology Department Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Serviço de Oftalmologia, Hospital de São Sebastião
Santa Maria da Feira, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSS-01-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.